AtaiBeckley (ATAI) Goodwill (2024 - 2026)
AtaiBeckley's (ATAI) quarterly Goodwill came in at $300000.0 in Q1 2026, little changed quarter-over-quarter from $300000.0 in Q4 2025.
AtaiBeckley (ATAI) Goodwill (2024 - 2026) Analysis & Trends
AtaiBeckley (ATAI) has 2 years of Goodwill data on file, last reported at $331000.0 in Q3 2025.
- On a quarterly basis, Goodwill changed N/A year-over-year to $300000.0 in Q1 2026; TTM through Mar 2026 was $300000.0, a N/A change from a year earlier, with the FY2025 full-year figure at $300000.0, changed 0.0% from the prior year.
- Goodwill held at $300000.0 in Q1 2026 per ATAI's latest filing, from $300000.0 in the prior quarter.
- Across five years, Goodwill topped out at $300000.0 in Q4 2024 and bottomed at $300000.0 in Q4 2024.
- The 3-year median for Goodwill is $300000.0 (2024), against an average of $300000.0.
- Biggest YoY gain for Goodwill was 0.0% in 2025; the steepest drop was 0.0% in 2025.
- Year by year, Goodwill stood at $300000.0 in 2024, then changed by 0.0% to $300000.0 in 2025, then changed by 0.0% to $300000.0 in 2026.
- Per Business Quant, the three latest ATAI Goodwill figures stand at $300000.0 (Q1 2026), $300000.0 (Q4 2025), and $300000.0 (Q4 2024).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | AtaiBeckley | 2.56 Bn | 2.56 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 300,000.00 |
| Dec 31, 2025 | 300,000.00 |
| Sep 30, 2025 | 331,000.00 |
| Jun 30, 2025 | 331,000.00 |
| Mar 31, 2025 | 300,000.00 |
| Dec 31, 2024 | 300,000.00 |
| Dec 31, 2024 | 300,000.00 |